Prognóstico de pacientes com COVID-19 e doenças crônicas

uma revisão sistemática

Autores

  • Daniela Évilla Gomes Arruda Centro Universitário de Patos - UNIFIP
  • Domettila Dantas Sena Martins Centro Universitário de Patos - UNIFIP
  • Isabel Fiuza Menezes da Silva Centro Universitário de Patos - UNIFIP
  • Milena Nunes Alves de Sousa Centro Universitário de Patos

DOI:

https://doi.org/10.51723/ccs.v31i03.748

Palavras-chave:

COVID-19, Doenças Crônicas, Mortalidade

Resumo

Objetivos: identificar, sintetizar e avaliar o risco de mortalidade em pacientes com doenças crônicas acometidos por COVID-19. Método: revisão sistemática. Busca nas bases de dados PUBMED, Science Direct, EBSCOhost e The BMJ com descritores: covid-19, chronic disease, mortality e “cohort study”. Resultados: as principais doenças crônicas foram Doenças Cardíacas, Doença Pulmonar Crônica, Hipertensão Arterial Sistêmica, Diabetes Mellitus e Doenças Renais Crônicas. O prognóstico desses pacientes acometidos por SARS-CoV-2 foi desfavorável, com alto risco de mortalidade. Conclusão: o prognóstico de pacientes com comorbidades pré-existentes indica maior necessidade de tratamento intensivo.

Downloads

Não há dados estatísticos.

Biografia do Autor

Daniela Évilla Gomes Arruda, Centro Universitário de Patos - UNIFIP

Acadêmica de Medicina. Centro Universitário de Patos - UNIFIP

Domettila Dantas Sena Martins, Centro Universitário de Patos - UNIFIP

Acadêmica de Medicina. Centro Universitário de Patos - UNIFIP

Isabel Fiuza Menezes da Silva, Centro Universitário de Patos - UNIFIP

Acadêmica de Medicina. Centro Universitário de Patos - UNIFIP

Milena Nunes Alves de Sousa, Centro Universitário de Patos

Doutorado em Promoção de Saúde. Docente do Curso de Medicina e Pró-Reitora de Pesquisa, Extensão e Pós-Graduação do Centro Universitário de Patos - UNIFIP

Referências

Lana RM, Coelho FC, Gomes MFC, Cruz OG, Bastos LS, Villela DAM, Codeço CT. The novel coronavirus (SARS-CoV-2) emergency and the role of timely and effective national health surveillance. Cadernos de Saúde Pública, March, 2020; 36(3), e00019620. https://doi.org/10.1590/0102-311x00019620

Sohrabi C, Alsafi Z, O'Neill N et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) [published correction appears in Int J Surg. 2020 May;77:217]. Int J Surg. 2020;76:71-76. doi:10.1016/j.ijsu.2020.02.034

Singh A. K.; Gupta R.; Misra A. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020; 14(4): 283-287.

Galvão C M, Sawada N O, Trevisan M A. Revisão sistemática: recurso que proporciona a incorporação das evidências na prática da Enfermagem. Rev Latino-am Enfermagem. 2004; 12 (3): 549-56.

Galvão T F, Pansani T S A, Harrad D. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol. Serv. Saúde, Brasília. 2015; 24 (2): 335-342.

Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos. Departamento de Ciência e Tecnologia. Diretrizes metodológicas: Sistema GRADE – Manual de graduação da qualidade da evidência e força de recomendação para tomada de decisão em saúde. Brasília: Ministério da Saúde; 2014.

Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. The Lancet. May, 2020; 395 (10238): 1715-1725. https://doi.org/10.1016/S0140-6736(20)30854-0

Chen T, Wu Di, Chen Huilong, Yan Weiming, Yang Danlei, Chen Guang et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ;March 2020; 368:m1091. https://doi.org/10.1136/bmj.m1091

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet; January 2020; 395 (10223):507-513. https://doi.org/10.1016/S0140-6736(20)30211-7

Docherty Annemarie B, Harrison Ewen M, Green Christopher A, Hardwick Hayley E, Pius Riinu, Norman Lisa et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020; 369:m1985. https://doi.org/10.1136/bmj.m1985

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. The Lancet. February, 2020; 395 (10223): 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5

Petrilli Christopher M, Jones Simon A, Yang Jie, Rajagopalan Harish, O’Donnell Luke, Chernyak Yelena et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. May 2020; 369 (m1966). https://doi.org/10.1136/bmj.m1966

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. May, 2020; 8(5): 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5

Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. 10.1016/j.annonc.2020.03.296

Zhang, J, Wang X, Jia X, Li J, Hu K, Chen G et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clinical Microbiology and Infection. June 2020; 26 (6):767-772, 2020.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648

Zheng Shufa, Fan Jian, Yu Fei, Feng Baihuan, Lou Bin, Zou Qianda et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020; 369 (m1443). https://doi.org/10.1136/bmj.m1443

Cen Y, Chen X, Shen Y, Zhang X-H, Lei Y, Xu C et al. Risk factors for disease progression in mild to moderate COVID-19 patients– a multi-center observational study. Clinical Microbiology and Infection. 2020. https://doi.org/10.1016/j.cmi.2020.05.041

Cummings JM, Baldwin MR, Abrams D, Jacobson AD, Meyer B, Balough EM et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. The Lancet. June 2020; 395 (10239): 1763-1770. https://doi.org/10.1016/S0140-6736(20)31189-2

Oke J.; Heneghan C. Global Covid-19 Case Fatality Rates. CEBM Research: Oxford COVID-19 Evidence Service. 2020

Mont’Alverne FJA , Lima FO, Nogueira RG, Freitas C C M, Neto Pontes O M, Silva G S et al. Management Of Acute Stroke And Urgent Neurointerventional Procedures During Covid-19 Pandemic. Recommendations of the Scientific Department on Cerebrovascular Diseases of the Brazilian Academy of Neurology, the Brazilian Society of Cerebrovascular Diseases and the Brazilian Society of Neuroradiology. Arq Neuropsiquiatr. 2020: in press. 10.1590/0004-282X20200053

Liang W, Guan W, Chen R, Wang W, Li J, Xu Ke et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology. March 2020; 21(3): 335-337. https://doi.org/10.1016/S1470-2045(20)30096-6

Emilsson V, Gudmundsson E F, Aspelund T, Jonsson B G, Gudjonsson A, Launer L J et al. Antihypertensive Medication Uses and Serum ACE2 Levels: ACEIs/ARBs Treatment Does Not Raise Serum Levels of ACE2. MedRxiv: the preprint server for health sciences. 2020. doi: 10.1101/2020.05.21.20108738

Downloads

Publicado

24.12.2020 — Atualizado em 09.04.2021

Versões

Como Citar

1.
Arruda D Évilla G, Martins DDS, Silva IFM da, Sousa MNA de. Prognóstico de pacientes com COVID-19 e doenças crônicas: uma revisão sistemática. Com. Ciências Saúde [Internet]. 9º de abril de 2021 [citado 16º de agosto de 2022];31(03):79-88. Disponível em: https://revistaccs.escs.edu.br/index.php/comunicacaoemcienciasdasaude/article/view/748

Edição

Seção

Fast Track : COVID-19

Artigos mais lidos pelo mesmo(s) autor(es)